Dimmock J R, Arora V K, Duffy M J, Reid R S, Allen T M, Kao G Y
College of Pharmacy, University of Saskatchewan, Saskatoon, Canada.
Drug Des Discov. 1992 Jul;8(4):291-9.
The synthesis of fourteen N-acyl derivatives of two 3,5-bis(arylidene)-4-piperidones was accomplished and these compounds were evaluated against L1210 leukemia cells in vitro. With one exception, the compounds had IC50 values of less than 10 microM and six of them had IC50 figures in the 0.2-0.6 microM range which were comparable to a reference drug melphalan. Twelve of the sixteen compounds showed specificity for human leukemia cell lines in the NCI in vitro screen. Studies using 1H NMR spectroscopy revealed that solutions of three N-acetylated compounds underwent deamination and possibly other reactions, the deaminated product itself being unstable in the solvent used.
合成了两种3,5-双(亚芳基)-4-哌啶酮的14种N-酰基衍生物,并在体外对这些化合物针对L1210白血病细胞进行了评估。除一个例外,这些化合物的IC50值小于10微摩尔,其中六种化合物的IC50值在0.2-0.6微摩尔范围内,与参考药物美法仑相当。在NCI体外筛选中,16种化合物中的12种对人白血病细胞系具有特异性。使用1H核磁共振光谱的研究表明,三种N-乙酰化化合物的溶液发生了脱氨基反应以及可能的其他反应,脱氨基产物本身在所用溶剂中不稳定。